A 50% increase in weight loss compared to semaglutide (22.5% vs 14.9%) seems too large to explain as mere enhancement
It improves insulin sensitivity and lowers blood sugar
A network meta-analysis of randomized controlled trials
GLP-1s May Lead to an Increased Risk of Post-Endoscopy Aspiration Pneumonia by ColoWrap, on May 15, 2024 In a recent large population-based study published in the peer-reviewed Gastroenterology journal, researchers found that glucagon-like peptide-1 receptor agonist (GLP-1RA) medicationssuch as Ozempic and Wegovy that are integrally transforming medications in the management of type 2 diabetes and obesityare associated with a higher risk of post-endoscopy aspiration pneumonia
Ascorbic acid also passes into breast milk and is considered safe during breastfeeding when used appropriately
The Technologies Propelling GLP-1 Analogues By Sampatkumarr Govind Donthula, MarketsandMarkets Glucagon-like peptide-1 (GLP-1) is a gastrointestinal hormone that stimulates insulin secretion, gene expression, and -cell proliferation
